Related Experiment Video
Updated: Jan 13, 2026

Deciphering and Imaging Pathogenesis and Cording of Mycobacterium abscessus in Zebrafish Embryos
Published on: September 9, 2015
Lung abscess as an adverse effect of Risankizumab.
Zarif Kazi1, Stuart Jesin1, Samir Ghimire1
1Internal Medicine, Department of Medicine, Maimonides Medical Center, Brooklyn, NY, USA.
This case highlights a potential link between Risankizumab (a biologic therapy) and serious lung infections. Further research is needed to understand the infectious risks associated with prolonged Risankizumab use.
Area of Science:
- Immunology
- Pulmonology
- Infectious Diseases
Background:
- Risankizumab is a biologic therapy used for prolonged durations.
- Characterizing infectious risks associated with Risankizumab is crucial.
- Patients on long-term Risankizumab may face increased susceptibility to infections.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Drugs for Treatment of Constipation-Predominant IBS
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

